A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors.
Blood
View this publicationBlood
View this publicationCurrent medical research and opinion
View this publicationJACC. Cardiovascular interventions
View this publicationBrain, behavior, and immunity
View this publicationInternational journal for parasitology. Drugs and drug resistance
View this publicationStatistical methods in medical research
View this publicationNature immunology
View this publicationGenes
View this publicationData in brief
View this publicationExperimental brain research
View this publication